ONGC approves unaudited financials and declares ₹8 per share interim dividend

Oil and Natural Gas Corporation Limited (ONGC) has announced its unaudited financial results for the quarter and half-year ended September 30, 2026. The company’s Board of Directors has approved these results and declared an interim dividend of ₹8 per equity share, representing 160% of face value, for the Financial Year 2026-27. The Record Date for dividend eligibility is November 12, 2026.

ONGC Board Approves Financial Results and Dividend

Oil and Natural Gas Corporation Limited (ONGC) has announced the outcome of its Board meeting held on November 5, 2026. The Board has approved the Unaudited Financial Results (Standalone and Consolidated) for the quarter and half-year ended September 30, 2026, along with the limited review report from its auditors.

Interim Dividend Declared

In a significant move for shareholders, the Board of Directors has declared the 1st Interim Dividend for the Financial Year 2026-27. The dividend has been set at a rate of ₹8 per equity share, which equates to 160% of the face value of ₹5/- each. The company has fixed November 12, 2026, as the Record Date for determining shareholder eligibility for this dividend payment. The dividend is expected to be paid within 30 days from the declaration date.

Inter-Corporate Loan Approved

The Board also approved a proposal to provide an inter-corporate loan to its wholly-owned subsidiary, ONGC Videsh Limited. This loan will be valid for 5 years and can have an outstanding value not exceeding ₹10,000 Crore at any point in time. The terms and conditions will be mutually agreed upon between ONGC as the lender and ONGC Videsh Limited as the borrower.

Disclosure on NCDs

The company disclosed that it had ₹1,000 Crore of unsecured Non-Convertible Debentures (NCDs) outstanding as of September 30, 2026. Security cover certificates were noted as not applicable for these unsecured NCDs.

Source: BSE

Previous Article

Diana Tea reports unaudited results for Q2 and H1 FY27

Next Article

Molbio Diagnostics Limited reports Q2 and H1 FY27 financial results